In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment

In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment

Human epidermal growth factor receptor (HER)2 imaging with radiolabeled trastuzumab might support HER2-targeted therapy. It is, however, frequently questioned whether HER2 imaging is also possible during trastuzumab treatment as the receptor might be saturated. We studied the effect of trastuzumab t...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Sietske B.M. Gaykema, Johan R. de Jong, Patrick J. Perik, Adrienne H. Brouwers, Carolien P. Schröder, Thijs H. Oude Munnink, Alphons H.H. Bongaerts, Elisabeth G.E. de Vries, Marjolijn N. Lub-de Hooge
Formatua: Artikulua
Hizkuntza:English
Argitaratua: SAGE Publishing 2014-07-01
Saila:Molecular Imaging
Sarrera elektronikoa:https://doi.org/10.2310/7290.2014.00011

Internet

https://doi.org/10.2310/7290.2014.00011

Antzeko izenburuak